Skip to main content
. 2022 Nov 9;10(4):2132–2141. doi: 10.1002/nop2.1460

TABLE 2.

Knowledge of cervical cancer questions

Knowledge questions

Total

n = 248 (%)

Chawama

n = 64 (%)

Chilenje

n = 35 (%)

Chipata

n = 25 (%)

Kanyama

n = 71 (%)

Matero

n = 53 (%)

p‐Value a
The possible causative agent for cervical cancer 111 (44.8) 12 (34.3) 29 (45.3) 16 (30.2) 7 (28.00) 47 (66.2) <.001
Having multiple sexual partners is a risk factor for cervical cancer 110 (45.5) 17 (53.1) 30 (46.9) 17 (33.3) 10 (40.0) 36 (51.4) .273
Infection by HPV is a risk of cervical cancer 182 (73.4) 24 (68.6) 53 (82.8) 39 (73.6) 19 (76.0) 47 (66.2) .258
Vaginal discharge is a symptom for cervical cancer 103 (41.7) 11 (31.4) 31 (48.4) 12 (23.1) 10 (40.0) 39 (54.9) .004
Vaginal bleeding is a symptom for cervical cancer 132 (53.2) 17 (48.6) 36 (56.3) 23 (43.4) 13 (52.0) 43 (60.6) .386
Cervical cancer is preventable 143 (57.7) 20 (57.1) 37 (57.8) 26 (49.1) 17 (68.0) 43 (60.6) .566
Vaccination with HPV vaccine prevents cervical cancer 151 (60.9) 21 (60.0) 39 (60.9) 28 (52.8) 18 (72.0) 45 (63.4) .568
Screening can detect cervical cancer early 160 (64.5) 21 (60.0) 44 (68.6) 30 (56.6) 21 (84.0) 44 (61.9) .158
Cervical cancer screening for HIV‐positive women is at any age 171 (68.9) 24 (68.6) 44 (68.8) 35 (66.0) 19 (76.0) 49 (69.0) .939
Overall score, mean (SD) 6.86 (2.76) 6.40 (2.76) 7.17 (2.68) 6.28 (2.47) 7.72 (1.74) 6.92 (3.26) .161 b

Abbreviation: SD, standard deviation.

a

p‐values from Pearson chi‐square test or Fisher's exact test as appropriate.

b

One‐way analysis of variance (ANOVA).